Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Hybrozyme-technology"

1 News Found

Alteogen strikes $285M deal with GSK subsidiary for innovative cancer drug delivery
Biopharma | January 23, 2026

Alteogen strikes $285M deal with GSK subsidiary for innovative cancer drug delivery

This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market